• Cancel
    Date：2024-05
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=773

    Recently, Vision Medicals announced a successful completion of D+ round funding worth hundreds of millions RMB, with Kequan Fund as lead-investor and Tianxin Fund as co-investor. Funds raised in this round will be primarily used to promote the research an

  • Cancel
    Date：2024-03

    Exclusive Financial Advisor to HYGIEIA

  • Cancel
    Date：2024-02
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=771

    On February 21, 2024, Yantai Dongcheng Biochemicals (002675) announced that its wholly-owned subsidiary, Yitai Pharmaceutical, intends to purchase the 99mTc-GSA injection and GSA cold kit (hereinafter referred to as the "target product") held by Rongcheng

  • Cancel
    Date：2024-02
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=770

    Today, Affection Animal Pharmaceuticals successfully completed a Series C funding round worth hundreds of millions of yuan. This equity financing was co-led by Yuanxi Haihe Fund and Songqing Shenhui Jiarui Private Investment Fund, with Guohai Innovation C

  • Cancel
    Date：2023-11
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=767

    This innovative platform specializes in recombinant protein drugs for metabolic diseases. QL Biopharm announces the completion of a nearly 200 million B+ round of financing. IMEIK and China US Green Fund led this financing round, with significant contrib

  • Cancel
    Date：2023-07
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=763

    In June, Sinovation, the leading domestic neurosurgery intelligent platform for diagnosis and minimally invasive surgery, announced the completion of a super-billion D+ round financing. The investors in this round include Xinda Kunpeng, TsingVentures, Pea

  • Cancel
    Date：2023-06
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=706

    The round was led by New Alliance Capital and Zhangkeherun Venture Capital, with participation from new investors Rockbleu Capital, Royal Fund, Zhuhai Huajin Capital, and Elikon Venture, and continued support from existing investors Delos Global Investmen

  • Cancel
    Date：2023-04
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=708

    Columbia China and Nanyan Group announce Nanyan Group's acquisition of Columbia China's clinic business. CEC Capital acted as exclusive financial advisor to Columbia China in this transaction.

  • Cancel
    Date：2023-04
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=711

    Shanghai Winning Health Software Technology Co., Ltd. ("Winning Health") recently raised RMB 300 million in its Series C financing round. The investment was led exclusively by Taiping Medical and Health Industry Fund, a subsidiary of China Taiping Insuran